152 related articles for article (PubMed ID: 27616074)
21. Critical Tools in Tableting Research: Using Compaction Simulator and Quality by Design (QbD) to Evaluate Lubricants' Effect in Direct Compressible Formulation.
Jiwa N; Ozalp Y; Yegen G; Aksu B
AAPS PharmSciTech; 2021 May; 22(4):151. PubMed ID: 33977355
[TBL] [Abstract][Full Text] [Related]
22. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
23. QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.
Singh B; Kaur A; Dhiman S; Garg B; Khurana RK; Beg S
AAPS PharmSciTech; 2016 Apr; 17(2):454-65. PubMed ID: 26238805
[TBL] [Abstract][Full Text] [Related]
24. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis.
Meltzer EO; Orgel HA; Backhaus JW; Busse WW; Druce HM; Metzger WJ; Mitchell DQ; Selner JC; Shapiro GG; Van Bavel JH
J Allergy Clin Immunol; 1993 Dec; 92(6):812-23. PubMed ID: 8258615
[TBL] [Abstract][Full Text] [Related]
25. Quality-by-design based fabrication of febuxostat-loaded nanoemulsion: Statistical optimization, characterizations, permeability, and bioavailability studies.
Gurumukhi VC; Sonawane VP; Tapadiya GG; Bari SB; Surana SJ; Chalikwar SS
Heliyon; 2023 Apr; 9(4):e15404. PubMed ID: 37128342
[TBL] [Abstract][Full Text] [Related]
26. In vitro effect of beclomethasone dipropionate and flunisolide on the mobility of human nasal cilia.
Stafanger G
Allergy; 1987 Oct; 42(7):507-11. PubMed ID: 3688375
[TBL] [Abstract][Full Text] [Related]
27. Comparative trial of acceptability of beclomethasone dipropionate and a new formulation of flunisolide.
Conley SF
Ann Allergy; 1994 Jun; 72(6):529-32. PubMed ID: 8203796
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
AAPS PharmSciTech; 2011 Mar; 12(1):337-43. PubMed ID: 21286880
[TBL] [Abstract][Full Text] [Related]
29. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
30. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
[TBL] [Abstract][Full Text] [Related]
31. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance.
Beg S; Sandhu PS; Batra RS; Khurana RK; Singh B
Drug Deliv; 2015; 22(6):765-84. PubMed ID: 24673611
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach.
Yerlikaya F; Ozgen A; Vural I; Guven O; Karaagaoglu E; Khan MA; Capan Y
J Pharm Sci; 2013 Oct; 102(10):3748-61. PubMed ID: 23918313
[TBL] [Abstract][Full Text] [Related]
33. Systematic Development and Optimization of an in-situ Gelling System for Moxifloxacin Ocular Nanosuspension using High-pressure Homogenization with an Improved Encapsulation Efficiency.
Khurana LK; Singh R; Singh H; Sharma M
Curr Pharm Des; 2018; 24(13):1434-1445. PubMed ID: 29611480
[TBL] [Abstract][Full Text] [Related]
34. Application of ICH Q9 Quality Risk Management Tools for Advanced Development of Hot Melt Coated Multiparticulate Systems.
Stocker E; Becker K; Hate S; Hohl R; Schiemenz W; Sacher S; Zimmer A; Salar-Behzadi S
J Pharm Sci; 2017 Jan; 106(1):278-290. PubMed ID: 27842971
[TBL] [Abstract][Full Text] [Related]
35. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Pitta SK; Dudhipala N; Narala A; Veerabrahma K
Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
[TBL] [Abstract][Full Text] [Related]
36. Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers.
Nolting A; Sista S; Abramowitz W
Biopharm Drug Dispos; 2001 Dec; 22(9):373-82. PubMed ID: 11870676
[TBL] [Abstract][Full Text] [Related]
37. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention.
Arora D; Nanda S
Int J Pharm; 2019 Aug; 567():118448. PubMed ID: 31226472
[TBL] [Abstract][Full Text] [Related]
38. Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach.
Sylvester B; Porfire A; Muntean DM; Vlase L; Lupuţ L; Licarete E; Sesarman A; Alupei MC; Banciu M; Achim M; Tomuţă I
J Liposome Res; 2018 Mar; 28(1):49-61. PubMed ID: 27788618
[TBL] [Abstract][Full Text] [Related]
39. Flufenamic Acid-Loaded Self-Nanoemulsifying Drug Delivery System for Oral Delivery: From Formulation Statistical Optimization to Preclinical Anti-Inflammatory Assessment.
Alshehri S; Imam SS; Hussain A; Alyousef AM; Altamimi M; Alsulays B; Shakeel F
J Oleo Sci; 2020 Oct; 69(10):1257-1271. PubMed ID: 32908093
[TBL] [Abstract][Full Text] [Related]
40. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
